Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 5 February 2025
STG320 for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites [ID1278]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social careStatus:Awaiting developmentExpected publication date: TBC
Benralizumab for previously treated severe nasal polyps [ID1659]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps TS ID 11918Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Depemokimab for treating chronic rhinosinusitis with nasal polyps ID 6449Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Betula verrucosa for previously treated moderate to severe rhinoconjunctivitis from tree pollen allergy in people 18 to 64 years ID 6462Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC